Daily Archives: December 13, 2014

How to cover Psoriasis/What not to say to someone with Psoriasis
So having Psoriasis isn #39;t very fun! It is a very itchy and noticeable (non-contagious!) skin disease that affects millions of people worldwide. In this video...

By: elyse reneau

More here:
How to cover Psoriasis/What not to say to someone with Psoriasis - Video

How to treat Psoriasis In Homeopathy | Homeocare International | Doctors Talk
Doctors Talk is an exclusive program by CVR Health TV in which a specialist will discuss about different health problems and suggest remedies. Watch CVR Health, the 24/7 health channel with...

By: CVR Health TV

View post:
How to treat Psoriasis In Homeopathy | Homeocare International | Doctors Talk - Video

Download Phototherapy Treatment Protocols for Psoriasis
Free Download Here: http://bit.ly/1sn13pD.

By: Lisa R. Hogan

See original here:
Download Phototherapy Treatment Protocols for Psoriasis - Video

Spelling Bee Words and Definitions Psoriasis
This video shows you how to say or pronounce Psoriasis and gives the definition of Psoriasis. What #39;s your definition of Psoriasis?

By: Spelling Bee and SAT Words

Visit link:
Spelling Bee Words and Definitions Psoriasis - Video

Reuters Dec 12, 2014, 02.22PM IST

(Novartis said its experimental)

ZURICH: Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson & Johnson's Stelara.

Results of the late-stage Phase IIIb study involving 679 patients with moderate to severe plaque psoriasis found those taking Cosentyx achieved clear or almost clear skin after 16 weeks of treatment.

On a secondary measure, patients achieved at least a 75 per cent improvement in disease severity at week four.

Plaque psoriasis is a painful and unsightly skin condition which is known to cause itching and scaling and affects approximately 125 million people.

The data follows results last year showing Cosentyx, also known as secukinumab, was superior to Amgen's Embrel in a head-to-head study.

Cosentyx is expected to be the first in a clutch of new treatments for plaque psoriasis which target the inflammation-causing protein interleukin-17 (IL-17) to gain market approval.

European regulators gave the green light to the drug last month, while an advisory panel to the US Food and Drug Administration unanimously recommended the use of the drug.

Other drugmakers working on new treatments include Eli Lilly , AstraZeneca and Amgen.

Here is the original post:
Novartis psoriasis drug tops Johnson & Johnson's Stelara in late-stage: Study